SEC Tracker
Get the app

Corvus Pharmaceuticals CRVS

Corvus Pharmaceuticals, Inc., entered into

Form
8-K
Filed
Period
Importance
Major
Document
8-K
  • Signs a material agreement (1.01)
  • Completes an acquisition or sale of assets (2.01)
  • Discloses other events (8.01)

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when Corvus Pharmaceuticals files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. DBV Technologies DBVT public float $251M, Jun 30, 2025
  2. Verastem VSTM public float $254M, Jun 30, 2025
  3. Annexon ANNX public float $244M, Jun 30, 2025
  4. Atea Pharmaceuticals AVIR public float $263M, Jun 30, 2025
  5. Vanda Pharmaceuticals VNDA public float $269M, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.